- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/7125 - Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters
Patent holdings for IPC class A61K 31/7125
Total number of patents in this class: 1888
10-year publication summary
|
72
|
74
|
113
|
116
|
119
|
140
|
133
|
184
|
184
|
121
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ionis Pharmaceuticals, Inc. | 890 |
131 |
| Alnylam Pharmaceuticals, Inc. | 1143 |
45 |
| Sarepta Therapeutics, Inc. | 383 |
34 |
| Wave Life Sciences Ltd. | 178 |
31 |
| ProQR Therapeutics II B.V. | 116 |
28 |
| The Board of Regents of the University of Texas System | 2221 |
28 |
| Hoffmann-La Roche Inc. | 3484 |
26 |
| Nippon Shinyaku Co., Ltd. | 323 |
25 |
| Geron Corporation | 166 |
24 |
| Arrowhead Pharmaceuticals, Inc. | 311 |
20 |
| University of Massachusetts | 2238 |
20 |
| Empirico Inc. | 86 |
20 |
| F. Hoffmann-La Roche AG | 7947 |
19 |
| The Regents of the University of California | 20137 |
19 |
| Daiichi Sankyo Company, Limited | 1875 |
18 |
| Antisense Therapeutics Ltd. | 29 |
17 |
| Regulus Therapeutics Inc. | 67 |
17 |
| Korro Bio, Inc. | 67 |
17 |
| Avidity Biosciences, Inc. | 162 |
17 |
| Bio-Path Holdings, Inc. | 26 |
16 |
| Other owners | 1316 |